What does ARS Pharmaceuticals, Inc. (SPRY) do?

ARS Pharmaceuticals, Inc. (SPRY) is a publicly traded company in the Healthcare sector.

What sector does SPRY operate in?

ARS Pharmaceuticals, Inc. operates in the Healthcare, specifically within the Pharmaceuticals industry. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find SPRY earnings analysis?

AlphaOS publishes an earnings intelligence page for ARS Pharmaceuticals, Inc. (SPRY) covering results, guidance context, and AI-assisted analysis. See /stocks/SPRY/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

SPRY

ARS Pharmaceuticals, Inc.

Healthcare · Pharmaceuticals

$4.13Sep 28, 2026

AI confidence 71% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

ARS Pharmaceuticals, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +114% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +114% YoY in Q2 FY2026

Pipeline evidence · 0d ago

SPRY's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on SPRY.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full SPRY earnings analysis

Reported figures for ARS Pharmaceuticals, Inc. — research only, not investment advice.

Revenue YoY: +114.1%

Latest Intelligence

Updated September 29, 2026

What happened recently for ARS Pharmaceuticals, Inc. (SPRY) — events, not interpretation.

Event: Reported Q2 2026 revenue +114% YoY.
Also: Last session September 28, 2026 at $4.13.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Building company intelligence…

ARS Pharmaceuticals, Inc. (SPRY)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for ARS Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:: Healthcare
Industry:: Pharmaceuticals
Market cap:: $410.72M
Revenue:: $22.68M

SPRY earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow ARS Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related & Connected

Connected companies and research pages from the AlphaOS knowledge graph.